PCR Analysis of Matrix Metalloproteinase 3 (MMP-3) Gene Promoter Polymorphism in Ovarian Cancer

Polish Journal of Pathology

Volumn 54, Issue 4, 2003, Pages 233-238

  Smolarz, Beata ^a   Szyłł, Krzysztof ^a   Romanowicz Makowska, Hanna ^a   Niewiadomski, Mariusz ^a   Kozłowska, Elzbieta ^a   Kulig, Andrzej ^a  

^a POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PARAFFIN; PRIMER DNA; STROMELYSIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER GROWTH; CANCER STAGING; CANCER TISSUE; CHEMISTRY; CONTROLLED STUDY; DISEASE COURSE; ENZYMOLOGY; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC CODE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; METHODOLOGY; OVARY CANCER; OVARY TUMOR; PATHOLOGY; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; PREDICTION; PROMOTER REGION;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; DNA PRIMERS; DNA, NEOPLASM; FEMALE; GENE FREQUENCY; HUMANS; LOSS OF HETEROZYGOSITY; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POSTMENOPAUSE; PROMOTER REGIONS (GENETICS);

EID: 1242330460     PISSN: 12339687     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Balduyck M, Zerimech F, Gouyer V, Lemaire R, Hemon B, Grard G, Thiebaut C, Lemaire V, Dacquembronne E, Duhem T, Lebrun A, Dejonghe MJ, Huet G: Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro. Clin Exp Metastasis 2000, 18, 171-178.
2. Baruch RR, Melinscak H, Lo J, Liu Y, Yeung O, Hurta RA: Altered matrix metalloproteinase expression associated with oncogene-mediated cellular transformation and metastasis formation. Cell Biol Int 2001, 25, 411-420.
3. Behrens J: The role of cell adhesion molecules in cancer invasion and metastasis. Breast Cancer Res Treat 1993, 24, 175-184.
4. Benbow U, Brinckerhoff CE: The AP1 site and MMP gene regulation: what is all the fuss about? Matrix Biol 1997, 15, 519-526.
5. Berek JS, Fu S, Hacker NF: Ovarian cancer. In: Novak's Gynecology. Berek JS, Adashi EY, Hillard PA, eds. Williams & Wilkins, Baltimore 1996, pp 1155-1230.
6. Birkedal-Hansen B, Pavelic ZP, Gluckman JL, Stambrook P, Li YQ, Stetler-Stevenson WG: MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues. Oral Dis 2000, 6, 376-382.
7. Bodey B, Bodey B Jr, Siegel SE, Kaiser HE: Matrix metalloproteinase expression in malignant melanomas: tumor-extracellular matrix interactions in invasion and metastasis. In-Vivo 2001, 15, 57-64.
8. Bodey B, Bodey B Jr, Siegel SE, Kaiser HE: Immunocytochemical detection of the expression of members of the matrix metalloproteinase family in adenocarcinomas of the pancreas. In-Vivo 2001, 15, 71-76.
9. Bodey B, Bodey BJr, Siegel SE, Kaiser HE: Immunocytochemical detection of matrix metalloproteinase expression in prostate cancer. In-Vivo 2001, 15, 65-70.
10. Borden P, Heller R: Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit Rev Eukaryotic Gene Expr 1997, 7, 159-178.
11. Buttice G, Duterque-Coquillaud M, Basuyaux JP, Carrere S, Kurkinen M, Stehelin D: Erg and Ets family member, differentially regulates human collagenase-1 (MMP-1) and stromelysin 1 (MMP-3) gene expression by physically interacting with the Fos/Jun complex. Oncogene 1996, 13, 2297-2306,
12. Carrell TWG, Burnand KG, Wells GMA, Clements JM, Smith A: Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation 2002, 105, 477-482.
13. Chambers AF, Matrisian LM: Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997, 89, 1260-1270.
14. Dano K, Andreasen PA, Grondahl-Hansen K, Kristensen K, Nielsen LS, Skriver L: Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 1985, 44, 139-266.
15. Dano K, Romer J, Nielsen BS, Bjorn S, Pyke C, Rygaard J, Lund R: Cancer invasion and tissue remodeling - cooperation of protease systems and cell types. APMIS 1999, 107, 120-127.
16. Delany AM, Brinckerhoff CE: Post-transcriptional regulation of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblast. J Cell Biochem 1990, 50, 400-410.
17. Ghilardi G, Biondi ML, Caputo M, Leviti S, DeMonti M, Guagnellini E, Scorza R: A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. Clin Cancer Res 2002, 8, 3820-3823.
18. Henriet P, Blavier L, DeClerck YA: Tissue inhibitors of metalloproteinases (TIMP) and proliferation. APMIS 1999, 107, 111-119.
19. Herrera CA, Xu L, Bucana CD, Silva G, Hess R, Gershenson DM, Fidler IJ: Expression of metastasis-related genes in human epithelial ovarian tumors. Int J Oncol 2002, 20, 5-13,
20. Kolomecki K, Stepien H, Bartos M, Kuzdak K: Usefulness of VEGF, MMP-2, MMP-3 and TIMP-2 serum level evaluation in patients with adrenal tumours. Endocr Regul 2001, 35, 9-16.
21. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 1991, 64, 327-336.
22. Majka S, McGuire PG, Das A: Regulation of matrix metalloproteinase expression by tumor necrosis factor in a murine model of retinal neovascularization. Invest Ophthalmol Vis Sci 2002, 43, 260-266.
23. Meyer T, Hart IR: Mechanisms of tumour metastasis. Eur J Cancer 1998, 34, 214-221.
24. Mignatti P, Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993, 73, 161-195.
25. Muller D, Li DQ, Tseng SC: Regulation of collagenase, stromelysin and gelatinase B in human conjunctival and conjunctivochalasis fibroblasts by interleukin 1-beta and tumor necrosis factor alpha. Invest Ophthalmol Vis Sci 2000, 41, 2922-2929.
26. Nikkola J, Vihinen P, Vlaykova T, Hahka KM, Kahari M, Pyrhonen S: High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma. Int J Cancer 2002, 97, 432-438.
27. Ribbens C, Martin PM, Franchimont N, Kaiser MJ, Jaspar JM, Damas P, Houssiau FA, Malaise MG: Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment. Ann Rheum Dis 2002, 61, 161-166.
28. Sapi E, Flick M, Rodov S, Kancinski B: Ets-2 transdominant mutant abolishes anchorage-independent and macrophage colony-stimulating factor-stimulated invasion by BT20 breast carcinoma cells. Cancer Res 1998, 58, 1027-1033.
29. Sasaki H, Yukiue H, Moiriyama S, Kobayashi Y, Nakashima Y, Kaji M, Kiriyama M, Fukai I, Yamakawa Y, Fujii Y: Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer. J Surg Res 2001, 101, 242-247.
30. Satsangi J, Chapman RW, Haldar N, Donaldson P, Mitchell S, Simmons J, Norris S, Marshall SE, Bell JI, Jewell DP, Welsh KI: A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis. Gastroenterology 2001, 121, 124-130.
31. Wasylyk B, Hahn SL, Giovane A: The Ets family of transcription factors. Eur J Biochem 1993, 211, 7-18.
32. White LA, Maute C, Brinckerhoff CE: Ets sites in the promoters of the matrix metalloproteinases collagenase (MMP-1), stromelysin (MMP-3) are auxiliary elements that regulate basal and phorbol-induced transcription. Connect Tissue Res 1997, 36, 321-335.
33. Van Noorden JF, Meade-Tollin LC, Bosman FT: Metastasis. Am Sci 1998, 86, 130-141.
34. Yoon S, Tromp G, Vongpunsawad S, Ronkainen A, Juvonen T, Kuivaniemi H: Genetic analysis of MMP-3, MMP-9 and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms. Biochem Biophys Res Commun 1999, 265, 563-568.